Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
During 1985–1990 the U.S. National Cancer Institute (NCI) phased out its murine leukemia P388 anticancer drug screening program and developed as the replacement a new in vitro primary screen based upon a diverse panel of human tumor cell lines. For each substance tested, the screen generates a remarkably reproducible and characteristic profile of differential in vitro cellular sensitivity, or lack thereof, across the 60 different cell lines comprising the panel. Several investigational approaches to display, analysis, and interpretation of such profiles and databases, derived from the testing of tens of thousands of substances during the past 4–5 years since the NCI screen became fully operational, have been explored. A variety of useful, practical applications of the in vitro screen have become apparent. As these applications continue to evolve, they are proving to be complementary to diverse other anticancer screening and drug discovery strategies being developed or pursued elsewhere. Reviewed herein are some practical considerations and selected specific examples, particularly illustrating research applications of the NCI screen that may be more broadly applicable to the search for new anticancer drug development leads with novel profiles of antitumor activity and/or mechanisms of action. © 1995 Wiley‐Liss, Inc. This article is a US Government work and, as such, is in the public domain in the United States of America.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in December 1992, MDA‐MB‐435 was added to the NCI‐60 cell line panel for use in anticancer drug screening, where it was initially described as a “breast” cancer cell line.17”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [17]
Citations
Cites
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
Self-citationMonks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.11.757 · Cited by 3,289
Self-citationA Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
Soule, H. D., Vazquez, J., Long, A., Albert, S., & Brennan, M. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1409 · Cited by 2,449
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn, M. E., Ks, N., Ohnuki, Y., Lechner, J. F., & Jones, L. W. (1979) · PubMed · Cited by 2,121
Breast Tumor Cell Lines From Pleural Effusions2
Cailleau, R., Young, R., Olivé, M., & Reeves, W. J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/53.3.661 · Cited by 1,015
Paull, K. D., Shoemaker, R. H., Hodes, L., Monks, A., Scudiero, D. A., Rubinstein, L., Plowman, J., & Boyd, M. R. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1088 · Cited by 967
Self-citationRubinstein, L. V., Shoemaker, R. H., Paull, K. D., Simon, R. M., Tosini, S., Skehan, P., Scudiero, D. A., Monks, A., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1113 · Cited by 927
Self-citationIsolation of a human prostate carcinoma cell line (DU 145)
Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., & Paulson, D. F. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910210305 · Cited by 926
Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
Cailleau, R., Olivé, M., & Cruciger, Q. V. J. (1978) · In Vitro · doi:10.1007/bf02616120 · Cited by 679
Establishment and characterization of a cell line of human breast carcinoma origin
Keydar, I., Chen, L., Karby, S., Weiss, F. R., Delarea, J., Radu, M., Chaitcik, S., & Brenner, H. J. (1979) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(79)90139-7 · Cited by 650
Research works printed but not linked: 6
- Acton EM, 1992, Anticancer specificity of some ellipticinium salts against human brain tumors in vitro, Proc Am Assoc Cancer Res, 33, 488
- Boyd MR, 1986, Accomplishments in Oncology, Vol 1, Cancer Therapy: Where Do We Go From Here?, 68
- Boyd MR, 1989, Cancer: Principles and Practice of Oncology Updates, 1
- Buolamwini JK, 1994, Searching for new molecular targets for therapy of cancer and AIDS: Characterization by 2D protein gel electrophoresis, Proc Am Assoc Cancer Res, 35, 613
- Grever MR, 1994, Status of in vivo evaluations in the NCI anticancer drug discovery program, Proc Am Assoc Cancer Res, 35, 369
- Stinson SF, 1992, Morphologic and immunocytochemical characteristics of human tumor cell lines for use in an anticancer drug screen, Anticancer Res, 12, 1035
Cited by
Items 601–700 of 1,000
Šafranko, S., Janđel, K., Kovačević, M., Stanković, A., Sikirić, M. D., Mandić, Š., Széchenyi, A., Glavaš‐Obrovac, L., Leventić, M., Strelec, I., et al. (2023) · Chemosensors · doi:10.3390/chemosensors11040205 · Cited by 30
Antitumor constituents from the leaves of Carya cathayensis.
Cao, X., Ding, Z., Jiang, F., Ding, X., Chen, J., Chen, S., & Lv, G. (2012) · PubMed · doi:10.1080/14786419.2011.628174 · Cited by 30
Ashour, F. A., Rida, S. M., El-Hawash, S. A., El‐Semary, M. M., & Badr, M. H. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9612-6 · Cited by 30
Novel acetamidothiazole derivatives: Synthesis and in vitro anticancer evaluation
Ali, A. R., El‐Bendary, E. R., Ghaly, M. A., & Shehata, I. A. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.08.021 · Cited by 31
Rostom, S. A. F., Faidallah, H. M., & Al‐Saadi, M. S. (2010) · Medicinal Chemistry Research · doi:10.1007/s00044-010-9469-0 · Cited by 30
Waleh, N. S., Murphy, B. J., & Zaveri, N. T. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.08.006 · Cited by 30
Penicillosides A and B: new cerebrosides from the marine-derived fungus Penicillium species
Murshid, S. S. A., Badr, J. M., & Youssef, D. T. A. (2015) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2015.09.007 · Cited by 30
Structure-antioxidant and anti-tumor activity of Teucrium polium phytochemicals
Elmasri, W. A., Hegazy, M. F., Mechref, Y. S., & Paré, P. W. (2015) · Phytochemistry Letters · doi:10.1016/j.phytol.2015.11.007 · Cited by 30
Structure–anticancer activity relationships among 4-azolidinone-3-carboxylic acids derivatives
Kaminskyy, D. V., & Lesyk, R. (2010) · Biopolymers and Cell · doi:10.7124/bc.000150 · Cited by 30
Ewida, M. A., Ella, D. A. A. E., Lasheen, D. S., Ewida, H. A., El‐Gazzar, Y. I., & El‐Subbagh, H. I. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.08.010 · Cited by 30
Tyumkina, T. V., Makhmudiyarova, N. N., Kiyamutdinova, G. M., Mescheryakova, E. S., Bikmukhametov, K. S., Abdullin, M. F., Khalilov, L. M., Ибрагимов, А. Г., & Dzhemilev, U. M. (2018) · Tetrahedron · doi:10.1016/j.tet.2018.01.045 · Cited by 30
Khalil, O. M., Gedawy, E. M., El‐Malah, A., & Adly, M. E. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.10.058 · Cited by 30
Radwan, M. O., Ciftci, H. I., Ali, T. F. S., Ellakwa, D. E., Koga, R., Tateishi, H., Nakata, A., Ito, A., Yoshida, M., Okamoto, Y., et al. (2019) · Molecules · doi:10.3390/molecules24183295 · Cited by 30
Ahmed, M. F. E., & Santali, E. Y. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104842 · Cited by 30
Antineoplastic activity of fused nitrogen-phosphorus heterocycles and derived phosphonates
Abdou, W. M., Barghash, R. F., & Khidre, R. E. (2013) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-013-0950-6 · Cited by 30
Das, U., Pati, H. N., Panda, A. K., Clercq, E. D., Balzarini, J. M., Molnar, J. A., Baráth, Z., Ocsovszki, I., Kawase, M., Zhou, L., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.04.021 · Cited by 30
Lamellarin D Bioconjugates I: Synthesis and Cellular Internalization of PEG-Derivatives
Plá, D., Francesch, A., Calvo, P., Cuevas, C., Aligué, R., Alberício, F., & Álvarez, M. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800503k · Cited by 30
Cytotoxic 8,9-secokaurane diterpenes from a New Zealand liverwort, Lepidolaena taylorii
Perry, N. B., Burgess, E. J., & Tangney, R. S. (1996) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)82971-1 · Cited by 30
Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines
Xiao, X., Miao, Z., Antony, S., Pommier, Y. G., & Cushman, M. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.03.101 · Cited by 30
On topography and functionality in the B-D rings of cephalostatin cytotoxins
LaCour, T. G., Guo, C., Ma, S., Jeong, J. U., Boyd, M. R., Matsunaga, S., Fusetani, N., & Fuchs, P. L. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00430-8 · Cited by 30
Self-citationKhodair, A. I., El‐Subbagh, H. I., & Al-Obaid, A. M. (1998) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426509808035741 · Cited by 30
Abdel‐Aziem, A., Rashdan, H. R. M., Ahmed, E. M., & Shabaan, S. N. (2018) · Green Chemistry Letters and Reviews · doi:10.1080/17518253.2018.1556743 · Cited by 29
Kessler, M. D., Bateman, N. W., Conrads, T. P., Maxwell, G. L., Hotopp, J. C. D., & O’Connor, T. D. (2019) · Cancer · doi:10.1002/cncr.32020 · Cited by 29
Ali, A., Ali, A., Tahir, A., Bakht, M. A., Salahuddin, S., & Ahsan, M. J. (2021) · Plants · doi:10.3390/plants10081559 · Cited by 29
Abou‐Seri, S. M., Eissa, A. A. M., Behery, M. G. M., & Omar, F. A. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105334 · Cited by 29
Ibrahim, H. S., Abdelrahman, M. A., Nocentini, A., Bua, S., Abdel‐Aziz, H. A., Supuran, C. T., Abou‐Seri, S. M., & Eldehna, W. M. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105888 · Cited by 29
Ahsan, M. J., Choudhary, K., Ali, A., Ali, A., Azam, F., Almalki, A. H., Santali, E. Y., Bakht, M. A., Tahir, A., & Salahuddin, S. (2022) · Plants · doi:10.3390/plants11212835 · Cited by 29
Agarwal, M., Afzal, O., Salahuddin, S., Altamimi, A. S. A., Alamri, M. A., Alossaimi, M. A., Sharma, V., & Ahsan, M. J. (2023) · ACS Omega · doi:10.1021/acsomega.3c01462 · Cited by 30
Potential anticancer compound from Cerbera odollam.
Syarifah, M. M. S., Nurhanan, M. Y., Haffiz, J. M., Ilham, A. M., Getha, K., Asiah, O., Norhayati, I., Sahira, H. L., & Suryani, S. (2011) · JOURNAL OF TROPICAL FOREST SCIENCE · Cited by 29
Das, S., Das, U., Sakagami, H., Umemura, N., Iwamoto, S., Matsuta, T., Kawase, M., Molnar, J. A., Serly, J., Gorecki, D. K. J., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.02.042 · Cited by 29
Raffa, D., Maggio, B., Plescia, F., Cascioferro, S., Plescia, S., Raimondi, M. V., Daidone, G., Tolomeo, M., Grimaudo, S., Cristina, A. D., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.03.067 · Cited by 29
Singh, P., Mittal, A., Bhardwaj, A., Kaur, S., & Kumar, S. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.010 · Cited by 29
Bansal, R., & Guleria, S. (2008) · Steroids · doi:10.1016/j.steroids.2008.07.004 · Cited by 29
Perković, I., Tršinar, S., Žanetić, J., Kralj, M., Martin‐Kleiner, I., Balzarini, J. M., Hadjipavlou‐Litina, D., Katsori, A., & Zorc, B. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.663366 · Cited by 29
Synthesis and docking studies of novel benzopyran-2-ones with anticancer activity
Ismail, M. M. F., Rateb, H. S., & Hussein, M. M. M. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.05.050 · Cited by 29
Plá, D., Martí, M., Farrera‐Sinfreu, J., Pulido, D., Francesch, A., Calvo, P., Cuevas, C., Royo, M., Aligué, R., Alberício, F., et al. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800504t · Cited by 29
Tseng, C.-H., Chen, Y., Yang, C., Cheng, C., Han, C., & Tzeng, C. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.05.035 · Cited by 29
High-throughput measurements of the optical redox ratio using a commercial microplate reader
Cannon, T. M., Shah, A. T., Walsh, A. J., & Skala, M. C. (2015) · Journal of Biomedical Optics · doi:10.1117/1.jbo.20.1.010503 · Cited by 29
New furostanol saponins from the bulbs of Allium macrostemon Bunge and their cytotoxic activity
Chen, H., Chen, H., Chen, H., Yang, M., Wang, Z., Wang, X., Wang, N., Yang, M., Wang, Z., Wang, X., et al. (2007) · Die Pharmazie · doi:10.31083/ph.2007.7.6725 · Cited by 29
Synthesis and Cytotoxic Evaluation of Some Cribrostatin–Ecteinascidin Analogues
Wright, B. J. D., Chan, C., & Danishefsky, S. J. (2008) · Journal of Natural Products · doi:10.1021/np800022x · Cited by 29
Hassan, G. S. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0649-6 · Cited by 29
The Dolastatins: Novel Antitumor Agents from Dolabella auricularia
Flahive, E. J., & Srirangam, J. K. (2005) · CRC Press eBooks · doi:10.1201/9781420039658.ch11 · Cited by 30
Ewida, M. A., Ella, D. A. A. E., Lasheen, D. S., Ewida, H. A., El‐Gazzar, Y. I., & El‐Subbagh, H. I. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.05.025 · Cited by 29
Abo-Ashour, M. F., Eldehna, W. M., George, R. F., Abdel‐Aziz, M. M., Elaasser, M. M., Abou‐Seri, S. M., & Gawad, N. M. A. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0327 · Cited by 29
Kachaeva, M. V., Hodyna, D. M., Obernikhina, N., Pilyo, S. G., Kovalenko, Y. S., Prokopenko, V. M., Kachkovsky, O. D., & Броварец, В. С. (2019) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.3711 · Cited by 29
To, K. K. W., Wang, X., Yu, C. W., Ho, Y., & Au‐Yeung, S. C. F. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.07.009 · Cited by 29
Design, Synthesis and Mechanistic Studies of Novel Imidazo[1,2-A]Pyridines as Anticancer AgentsPreprint
Ismael, A. S., Amin, N. H., El‐Saadi, M. T., & Abdel-Rahman, H. M. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4063470 · Cited by 29
Moustafa, A. H., AboulMagd, A. M., Ali, A. M., Khodairy, A., Marzouk, A. A. E., Nafady, A., & Nemr, M. T. M. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107410 · Cited by 29
Synthesis and biological evaluation of new imidazo[2,1-b]thiazole derivatives as anticancer agents
Karaman, B., & Ulusoy-Güzeldemirci, N. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-016-1684-x · Cited by 28
Altamimi, A. S. A., El‐Azab, A. S., Abdel‐Hamide, S. G., Alamri, M. A., Bayoumi, A. H., Alqahtani, S. M., Alabbas, A. B., Altharawi, A., Alossaimi, M. A., & Mohamed, M. A. (2021) · Molecules · doi:10.3390/molecules26102992 · Cited by 28
Khedkar, H., Wang, Y., Yadav, V. K., Srivastava, P., Lawal, B., Mokgautsi, N., Sumitra, M. R., Wu, A. T. H., & Huang, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115895 · Cited by 28
Matarneh, C. M. A., Mangalagiu, I. I., Shova, S. G., & Danac, R. P. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1039530 · Cited by 28
Sayed, M. T. E., Ahmed, K. M., Mahmoud, K., & Hilgeroth, A. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.12.008 · Cited by 31
The development of thieno[2,3-b]pyridine analogues as anticancer agents applying in silico methods
Arabshahi, H. J., Leung, E. Y., Barker, D. L. A., & Reynisson, J. (2013) · MedChemComm · doi:10.1039/c3md00320e · Cited by 28
Atamanyuk, D. V., Zimenkovsky, B. S., Atamanyuk, V., & Lesyk, R. (2013) · Synthetic Communications · doi:10.1080/00397911.2013.800552 · Cited by 28
Synthesis of [1,2,4]triazolo[1,5-a]pyridines of potential PGE2 inhibitory properties
Girgis, A. S., & Barsoum, F. F. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.09.049 · Cited by 28
Kaminskyy, D. V., Khyluk, D., Vasylenko, O., & Lesyk, R. (2011) · Tetrahedron Letters · doi:10.1016/j.tetlet.2011.11.095 · Cited by 28
Novel Pyrimidinone Derivatives: Synthesis, Antitumor and Antimicrobial Evaluation
Taher, A. T., & Helwa, A. A. (2012) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.60.521 · Cited by 28
Synthesis, antibacterial and anticancer evaluation of 5-substituted (1,3,4-oxadiazol-2-yl)quinoline
Salahuddin, S., Mazumder, A., & Yar, M. S. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1308-2 · Cited by 28
Al-Mohizea, A. M., Al-Omar, M. A., Abdalla, M. M., & Amr, A. E. E. (2011) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2011.10.017 · Cited by 27
Holota, S. M., Komykhov, S., Sysak, S., Gzella, A. K., Cherkas, A., & Lesyk, R. (2021) · Molecules · doi:10.3390/molecules26041162 · Cited by 27
Sharma, R., Jadav, S. S., Yasmin, S., Bhatia, S., Khalilullah, H., & Ahsan, M. J. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1146-2 · Cited by 27
QSAR modeling, synthesis and bioassay of diverse leukemia RPMI-8226 cell line active agents
KATRITZKY, A. R., Girgis, A. S., Slavov, S. H., Tala, S. R., & Stoyanova‐Slavova, I. B. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.08.033 · Cited by 29
Synthesis and antitumor activity of goniofufurone analogues
Mereyala, H. B., Gadikota, R. R., Joe, M., Arora, S. K., Dastidar, S. G., & Agarwal, S. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00164-9 · Cited by 27
Basarić, N., Cindro, N., Bobinac, D., Uzelac, L., Mlinarić‐Majerski, K., Kralj, M., & Wan, P. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05338h · Cited by 27
Lozynskyi, A., Zimenkovsky, B. S., Nektegayev, I. A., & Lesyk, R. (2015) · Heterocyclic Communications · doi:10.1515/hc-2014-0204 · Cited by 27
Afzal, O., Akhtar, M. S., Kumar, S., Ali, M. R., Jaggi, M., & Bawa, S. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.05.038 · Cited by 27
Montoya, A. L., Jairo Quiroga, P., Abonía, R., Derita, M., Sortino, M. A., Ornelas, A., Zacchino, S. A., & Braulio Insuasty, O. (2016) · Molecules · doi:10.3390/molecules21080969 · Cited by 30
Farag, A., Ewida, H. A., & Ahmed, M. S. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.011 · Cited by 27
Ibrahim, H. S., Eldehna, W. M., Fallacara, A. L., Ahmed, E. R., Ghabbour, H. A., Elaasser, M. M., Botta, M., Abou‐Seri, S. M., & Abdel‐Aziz, H. A. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0288 · Cited by 27
Singh, I., Luxami, V., & Paul, K. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob02973c · Cited by 28
Shyyka, O. Y., Pokhodylo, N. T., & Finiuk, N. S. (2019) · Biopolymers and Cell · doi:10.7124/bc.000a0f · Cited by 27
Buzun, K., Kryshchyshyn‐Dylevych, A., Senkiv, J., Roman, O., Gzella, A. K., Bielawski, K., Bielawska, A., & Lesyk, R. (2021) · Molecules · doi:10.3390/molecules26103057 · Cited by 27
Acosta‐Guzmán, P., Butassi, E., Braulio Insuasty, O., Ortíz, A., Abonía, R., Zacchino, S. A., & Jairo Quiroga, P. (2015) · Molecules · doi:10.3390/molecules20058499 · Cited by 27
Abegaz, B. M. (2002) · Phytochemistry Reviews · doi:10.1023/a:1026066626537 · Cited by 27
Gangjee, A., Zhao, Y., Raghavan, S., Rohena, C. C., Mooberry, S. L., & Hamel, E. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400639z · Cited by 28
Gröger, K., Baretić, D., Piantanida, I., Marjanović, M., Kralj, M., Grabar, M., Tomić, S., & Schmuck, C. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00103a · Cited by 27
Subrahmanyam, D., Sharma, V. M., Akella, V., Sastry, T. V. R. S., Srinivas, A. S. S. V., Krishna, C. V., Deevi, D. S., Kumar, S. A., Babu, M. J., & Damodaran, N. K. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00005-6 · Cited by 27
Identification and characterization of A-105972, an antineoplastic agent.
Wu-Wong, J. R., Alder, J. D., Alder, L., Burns, D. J. W., Han, E. K.-H., Credo, B., Tahir, S. K., Dayton, B. D., Ewing, P. J., & Chiou, W. J. H. (2001) · PubMed · Cited by 27
Pettit, G. R., Orr, B., Herald, D. L., Doubek, D. L., Tackett, L. P., Schmidt, J. M., Boyd, M. R., Pettit, R. K., & Hooper, J. N. A. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00225-9 · Cited by 27
Self-citationSubrahmanyam, D., Akella, V., Rao, K. V., Sastry, T. V. R. S., Vandana, G., & Kumar, S. A. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00268-1 · Cited by 27
Canolol Dimer, a Biologically Active Phenolic Compound of Edible Rapeseed Oil
Kraljić, K., Brkan, V., Škevin, D., Srček, V. G., & Radošević, K. (2019) · Lipids · doi:10.1002/lipd.12132 · Cited by 26
El‐Hamamsy, M. H., Sharafeldin, N., El-Moselhy, T. F., & Tawfik, H. O. (2020) · Archiv der Pharmazie · doi:10.1002/ardp.202000060 · Cited by 27
Cuartas, V., Aragón-Muriel, A., Liscano, Y., Polo‐Cerón, D., Crespo-Ortiz, M. D. P., Jairo Quiroga, P., Abonía, R., & Braulio Insuasty, O. (2021) · RSC Advances · doi:10.1039/d1ra03509f · Cited by 26
Sayed, M. T. M., Halim, P. A., El‐Ansary, A. K., & Hassan, R. A. (2023) · Drug Development Research · doi:10.1002/ddr.22088 · Cited by 27
Hamed, O. A., El‐Sayed, N. A., Mahmoud, W. R., & Elmasry, G. F. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107413 · Cited by 27
Kamal, A., Laxman, E., Khanna, G. B. R., Reddy, P. S. M. M., Rehana, T., Arifuddin, M., Neelima, K., Kondapi, A. K., & Dastidar, S. G. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.05.026 · Cited by 26
Bioactive alkaloids from the Red Sea marine Verongid sponge Pseudoceratina arabica
Shaala, L. A., Youssef, D. T. A., Badr, J. M., Sulaiman, M. I., Khedr, A., & Sayed, K. A. E. (2015) · Tetrahedron · doi:10.1016/j.tet.2015.08.024 · Cited by 26
Near-Visible Light Generation of a Quinone Methide from 3-Hydroxymethyl-2-anthrol
Škalamera, Đ., Mlinarić‐Majerski, K., Martin‐Kleiner, I., Kralj, M., Wan, P., & Basarić, N. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo500290y · Cited by 26
Sayed, M. T. E., El‐Sharief, M. A. M. S., Zarie, E. S., Morsy, N. M., El‐Sheakh, A. R., Nayel, M., Voronkov, A., Berishvili, V. P., Sabry, N. M., Hassan, G. S., et al. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.11.002 · Cited by 26
Albuschat, R., Löwe, W., Weber, M., Luger, P., & Jendrossek, V. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.03.010 · Cited by 26
The NCI Human Tumor Cell Line (60-Cell) Screen
Boyd, M. R. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-739-0_3 · Cited by 31
Self-citationHu, K., & Yao, X. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200107000-00008 · Cited by 26
Schoenfeld, R. C., Conova, S., Rittschof, D., & Ganem, B. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00022-7 · Cited by 26
Nitroimidazoles, Part 2: Synthesis, Antiviral and Antitumor Activity of New 4‐Nitroimidazoles
Al-Masoudi, N. A., Al‐Soud, Y. A., Kalogerakis, A., Pannecouque, C. C., & Clercq, E. D. (2006) · Chemistry & Biodiversity · doi:10.1002/cbdv.200690055 · Cited by 26
Synthesis and antitumor activity of new thiosemicarbazones of 2-acetylimidazo[4,5- b ]pyridine
Mylonas, S., & Mamalis, A. (2005) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570420705 · Cited by 26
In vitro cytotoxicity of 5-aminosubstituted 20( S )-camptothecins. part 1
Subrahmanyam, D., Sharma, V. M., Venkateswarlu, A., Sastry, T. V. R. S., Kulakarni, A. P., Rao, D. S., & Reddy, K. V. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00130-3 · Cited by 26
Pletsas, D., Garelnabi, E. A. E., Li, L., Phillips, R. M., & Wheelhouse, R. T. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401121k · Cited by 25
Kazan, F., Yagci, Z. B., Bai, R., Özkırımlı, E., Hamel, E., & Özkırımlı, S. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.05.002 · Cited by 25
Synthesis, Pharmacological Evaluation, and In-Silico Studies of Thiophene Derivatives
Mishra, R., Kumar, N., & Sachan, N. (2021) · ONCOLOGIE · doi:10.32604/oncologie.2021.018532 · Cited by 26
Metadata
- Authors
- Boyd, M. R., & Paull, K. D.
- Affiliations
- Frederick National Laboratory for Cancer Research (US)
- National Cancer Institute (US)
- Corresponding author
- Boyd, Michael R.
- ORCID
- Boyd, Michael R.
- Venue
- Drug Development Research
- Publisher
- Wiley
- Published
- 1995-02
- Volume
- 34
- Issue
- 2
- Pages
- 91-109
- ISSN
- 0272-4391 (ISSN-L)
- 1098-2299
- OpenAlex
- W2118909720
- Cited by
- 1,572
- References
- 40
- Citations by year
- 2026: 28 · 2025: 57 · 2024: 79 · 2023: 58 · 2022: 68 · 2021: 81 · 2020: 74 · 2019: 51 · 2018: 58 · 2017: 39 · 2016: 56 · 2015: 61 · 2014: 78 · 2013: 84 · 2012: 79
- FWCI
- 30.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Development Research (publishedVersion, public-domain)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- anticancer drug discovery, human cancer cell lines, anticancer activity, lead compound identification, mechanism of action
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.